Related Experiment Video
Updated: May 25, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Disease gene identification strategies for exome sequencing
Christian Gilissen1, Alexander Hoischen, Han G Brunner
1Department of Human Genetics, Nijmegen Centre for Molecular Life Sciences and Institute for Genetic and Metabolic Disorders, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. c.gilissen@antrg.umcn.nl
Next-generation sequencing, including exome sequencing, is a powerful tool for identifying Mendelian disease genes. This approach successfully identifies new genes in about 60% of projects, with improvements expected.
Area of Science:
- Genomics
- Medical Genetics
Background:
- Mendelian diseases are caused by mutations in single genes.
- Identifying causative mutations requires analyzing vast amounts of genomic data.
Purpose of the Study:
- To review current strategies for identifying Mendelian disease genes using exome resequencing.
- To highlight the challenges and successes of variant prioritization in genetic studies.
Main Methods:
- Exome sequencing to analyze the protein-coding regions of the genome.
- Discussion of variant prioritization strategies based on patient data, inheritance patterns, and disease characteristics.
Main Results:
- Exome sequencing strategies are successful, identifying new Mendelian disease genes in approximately 60% of projects.
- The success rate is expected to increase with advancements in bioinformatics and sequencing technology.
Conclusions:
- Exome sequencing is a highly effective tool for Mendelian disease gene discovery.
- It is poised to become the primary method for identifying genes responsible for rare genetic disorders.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Modern Molecular Taxonomy
Pharmacogenomics: Identification of New Drug Targets
Sanger Sequencing
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.